- Heartland Dental ranks among best-in-state employers: Forbes
- Virginia dental practice opens 5th location
- 8 federal government, policy updates for dental leaders to know
- 24 women making moves in healthcare
- Investors renew fight against UnitedHealth, claiming $237M in insider stock sales
- Texas Health Resources CEO on forgoing M&A: ‘All those cases so far would be dilutive’
- What drives a US News Honor Roll hospital: 4 operational themes from 6 execs
- Florida oral surgery practice damaged in fire
- 6 DSOs making headlines
- Luigi Mangione admits he shot UnitedHealthcare CEO
- Cleveland Clinic posts 5% operating margin in Q2: 5 things to know
- The ‘hidden tax’ squeezing hospital supply chains
- DermCare Management, US Dermatology Partners form national dermatology group
- HCA plans $300M Florida hospital
- 346 healthcare organizations named Forbes’ best-in-state employers
- The real reason ASC anesthesia departments struggle — and it’s not operations
- Single payer system would save $1 trillion, 114,000 lives annually: Yale study
- Nevada cuts psychiatric residential placements for children from 35% to 16%
- Seattle Children’s expands with $103M ASC
- 5 cardiologists in the headlines
- The toughest talks ASC leaders have with physicians
- Alabama developers to break ground on $35M ASC
- The specialties driving ASC growth through 2031
- Is the behavioral health access problem actually a quality problem?
- Nurses at SSM Health outpatient practices move to unionize
- 62% of ASCs cancel, delay cases over anesthesia gaps
- Processed Foods Linked To Prostate Cancer Risk
- Screen Time Is Not All Bad For Kids' Brains
- Winter Is Coming: How Vaccines Help Protect Against Respiratory Illness
- Updated Statement Regarding the Division of Corporation Finance’s Role in the Exchange Act Rule 14a-8 Process
- Luigi Mangione pleads guilty in federal case over murder of UnitedHealthcare CEO Brian Thompson
- It's BMS vs. Celgene investors once more after US appeals court revives lawsuit
- Tavneos trial flagged for 'serious breaches' of protocol as EU regulators dissect market withdrawal decision
- Sleep Disturbances Linked To Genetic Alzheimer's Risk
- Pre-K Sets Kids Up For School Success, Study Says
- Expect Other Seniors To Act Their Age? Then Expect Problems With Your Own Memory, Study Says
- People With Disabilities Say Medicaid Income Limits Stifle Career Advancement
- A genomics library for the AI era
- BMS bags first FDA approval for CELMoD franchise with Zenbexus multiple myeloma nod
- My Husband Was Kicked Out of Hospice for Dying Too Slowly
- Trump Team’s Use of Arcane Budget Rule Threatens Medicaid Coverage
- Massachusetts moves to restrict kratom sales
- Meet the leaders of the fastest-growing dental practices
- Fierce Pharma Asia—Legend’s first profit; Taiho, Cullinan’s EGFR win; WuXi AppTec’s reprieve
- Will cardiology’s ASC strategy pay off? CVL’s new CEO is betting on it
- 5 numbers making dentists optimistic
- 25 state behavioral health policy updates
- Wisconsin woman accused of posing as fake dentist ordered to pay customer $144K
- Dentists battle insurance woes: 5 updates
- Philadelphia dentist dies at 86
- Mental healthcare provider gaps, by state
- 28 new behavioral health study findings to know
- 23 new behavioral health projects to know
- Major PBMs agree to offer TrumpRx pricing information to members
- Providence reports $400M operating improvement halfway through 2026
- A look at where Aetna is seeing value-based care success in Medicare Advantage
- Nationwide program to quit smoking would save US $12B: Study
- Rare Bacteria In Coastal Waters Has Killed 7 This Summer
- It's crunch time for Karyopharm as company faces potential default next month
- UNC Health Pardee completes 23-bed behavioral health center
- Oregon State Hospital superintendent out after less than a month
- March of Dimes: Maternity care deserts persist, Medicaid cuts threaten to curb access further
- Trump administration refers providers, PBMs to DOJ over youth gender care billing
- Socializing: A Prescription For Healthier Brain Aging
- Taking The Stairs May Lower Your Risk Of Dying From Heart Disease
- Obesity not a 'zero-sum game' as patients crave optionality, Novo CEO says: Reuters
- AZ's blood pressure newcomer Baxfendy fails to meet cost-effectiveness bar, ICER says
- How consumerization is reshaping pharma marketing
- Sweet Tooth? It Could Be Shaping Your Decisions, Study Says
- Stressed Parents Turn To Screens For Help, Study Finds
- Gambling Linked To Mental Health Problems Among College Students
- Hospitals Say They Found A Tool To Help Reduce Childbirth Risks: Wristbands
- Listen to the Latest ‘KFF Health News Minute’
- Readers Speak Out on Work Requirements, Federal Data Grab, Opioid Payback Cash
- People With Disabilities Say Medicaid’s Limits on Income Stifle Career Advancement
- Abbott to pump up blood supply with $1M college sports prize amid US crisis
- Neurocrine stands by blockbuster hopeful Vykat XR as Prader-Willi docs raise potential safety flags
- Appeals court tosses methodology for calculating NSA qualifying payment amounts
- UC San Diego Health, West Health launch $40M accelerator for 'tech-forward' coordinated care
- Epic releases Care Everywhere diagnostic image exchange to tackle healthcare's 'CD problem'
- FDA Wants More Information From Food Makers On New Food Chemicals
- Cityblock unveils partnership with Humana in North Carolina
- Antelope Recovery, offering SUD care for teens, to expand Spanish services in Colorado
- Legend interim CEO talks rising competition as Carvykti maker posts first profit
- Aspirin/Omega-3 Combo Matches Antibiotics In Treating Gum Disease, Trial Finds
- Endometriosis Linked To Higher Type 2 Diabetes Risk
- Cedar launches Kora Platform to build out agentic AI for medical billing
- Sharp HealthCare announces another reorganization affecting 260 workers
- Alfasigma gains arthritis drug, access to new markets with M&A play
- Common Health Coalition secures $100M from OpenAI Foundation to boost hepatitis C cure rates
- Lilly takes 6 companies to court for selling retatrutide knockoffs
- Tamiflu Helps Keep Severely Ill Kids Out Of The ICU, Study Finds
- 'Normal' Can Backfire During Doctor/Patient Discussions
- Experimental Pulse Oximeter Accurate Regardless Of Skin Tone, Researchers Say
- Suvi Health launches ambient AI solution for patients to reduce hospital stays and support care transitions
- The biggest payer and provider trends from Q2
- Patients Wary Of Governments, Companies Pushing AI As A Rural Healthcare Solution
- Years After He Quit Smoking, a Lung Cancer Scan Saved His Life
- Hospital Prepayment Requirements Add New Wrinkles to Patients’ Financial Responsibility
- Hospitals Say They Found a Tool To Help Reduce Childbirth Risks: Wristbands
- Fresenius pulls one batch of Actemra biosim over glass particle concerns
- Oracle Health debuts revamped patient portal with an AI upgrade
- Snapchat creates ad format to support pharma disclosure needs
- CMS ends Medicaid, CHIP funding for gender-affirming care for minors
- Healthcare CFOs face growing decision-making expectations. Many say they aren't ready
- Assort Health rolls out AI agent to automate referrals for specialty practices and health systems
- Claims data transparency empowers employers to act on affordability: survey
- Hims & Hers posts $753M in Q2 revenue as it preps for push into peptide market
- Executive Order Calls For Fewer Routine Childhood Vaccines, Doctors Push Back
- Biopharma saw a Q2 sales boom led by Lilly, Sanofi, Regeneron and Astellas
- Real-World Performance Of Alzheimer's Drug, Leqembi, Matches Trial Data, Study Finds
- Study Finds Undisclosed Chemicals In Most Personal Care Products
- Senators introduce bipartisan legislation to further antimicrobial resistance research
- CMS' mandatory VBC programs brought substantial administrative costs for hospitals: study
- Attruby cruises toward blockbuster land as BridgeBio CEO spots ‘stabilizer-first’ ATTR market
- WuXi AppTec scores temporary win amid fight over DOD's Chinese military company brand
- Barbie And Ken Fade From Fantasy, Offer More Realistic Proportions, Study Finds
- Children Should Get Flu Vaccine, Top Pediatrics Group Recommends
- Together, Two Everyday Health Factors Double Death Risk In Midlife And Beyond
- Many States Cover Doula Care, But Access To A 'Birthing Bestie' Is Often Out Of Reach
- Patients Wary of Governments, Companies Pushing AI as a Rural Healthcare Solution
- A Federal Policy Is Complicating How Organizations Battle the Opioid Crisis
- Chairman Paul S. Atkins Letter to Robert Walley, Chair, CAT NMS Plan Operating Committee
- Trump signs executive order to overhaul pediatric vaccine recommendations
- Unapproved in US for decades, levosimendan stumbles in phase 3 as Tenax eyes narrow FDA path
- Jalapeño Recall Reaches Seven Grocery Chains In 26 States
- New Melanoma Drug, Tudriqev, Based On Herpes Virus Granted FDA Accelerated Approval
- Even Light Exercise May Lower Stroke Risk For People With A-fib
- Working At Home Makes Breastfeeding Harder, Not Easier, Study Says
- Kidney Dialysis: Here's What You Need To Know
- What 524B and QMSR Change About Medical Device Risk
- Taking Lean Manufacturing to the Next Level
- Why Few MedTech Sales Teams Are Using AI Where It Matters Most
- Abbott casts telenovela star Gabriela Spanic to take the drama out of colon cancer screening
- Zepbound Lowers Heart Attack, Stroke Risk Among Type 2 Diabetics
- Heart Problems Linked To Brain Shrinkage Among People With Genetic Risk For Alzheimer's
- Budget Battle Erupts In Nation's Capital Over Opioid Settlement Money
- Rising Global Heat Linked To Mental Health Risks In Children
- Why Organizations Miss Emerging Product Risk: Understanding the engineering mechanisms that remain hidden long before complaint trends become visible
- Update on the SEC’s Work Toward Treasury Clearing Implementation [August 2026]
- FDA Reverses Course, Approves First mRNA Flu Shot
- Therapy Dogs Aid Stroke Rehab
- Can Yoga Calm A Grumpy Gut?
- Leo Pharma readies rare disease education push for 2nd annual GPP awareness day
- The Interface is the Risk: A MedTech Blueprint for AI and System Integration
- Restoring Regulatory Clarity: Statement on Technical Amendments to Rule 0‑1(a)(7)
- Beyond the Status Report: Using LLMs to Reveal the True State of SaMD Development
- Headstands and Summervaults: A Statement on Crypto Vaults and Lending Strategies
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Seeking Public Comment on Seeking Public Capital: Remarks Before the Small Business Capital Formation Advisory Committee
Michigan healthcare freedom community forum
The National Vaccine Injury Compensation Program (VICP or NVICP) was established by the 1986 National Childhood Vaccine Injury Act (NCVIA) which was a response to concerns about the diphtheria, pertussis, and tetanus (DPT) vaccine. The Office of Special Masters of the U.S. Court of Federal Claims administers a no-fault system for litigating vaccine injury claims - except for the COVID-19 vaccines. People claiming injuries from the COVID-19 vaccines have to file a claim with the Countermeasures Injury Compensation Program (CICP). Both the NVICP and the CICP are part of the Health Resources & Services Administration (HRSA), but the claims outcomes have been quite different:
Lawsuit: COVID Vaccine Injury Claims Diverted to Unconstitutional 'Kangaroo Court'
A war on terror–era program is the only legal avenue for people seeking compensation for a COVID vaccine injury.
By Christian Britschgi | November 21, 2023People injured by the COVID-19 vaccines are suing the federal government, claiming the federal program they're forced to pursue compensation through is an opaque and unconstitutional "kangaroo court" that unjustly rejects almost all claims it receives.
"It has become far more obvious that the program offers nothing close to due process," says Christopher Dreisbach, the legal affairs director for React19, a patient group of the vaccine injured. "There's not [just] one thing about the program that can be tweaked and be fixed."
React19 is one of several plaintiffs challenging the constitutionality of the Countermeasures Injury Compensation Program (CICP). The other plaintiffs are all individuals whose compensation claims were rejected by the CICP, despite many having diagnoses from their doctors that the severe injuries they experienced within a few hours or days of receiving a COVID-19 vaccine were a result of the vaccine.
Their lawsuit was filed in October in the U.S. District Court for the Western District of Louisiana.
The CICP is currently the only avenue through which those with a COVID-19 vaccine injury can seek compensation.
A mix of federal law and pandemic-era emergency declarations bar the vaccine injured from suing vaccine manufacturers in civil court. Those with a COVID-19 vaccine injury are also prohibited from pursuing compensation through the standard Vaccine Injury Compensation Program (VICP)—a decades-old program that approves about 50 percent of injury claims in an expedited civil court–like process.
Each year, the VICP paid out $200 million in compensation and attorneys' fees, all of which are funded by an excise tax on vaccines.
Contrast that with the CICP, which has paid out a total of around $30,000 compensating eight people claiming a COVID-19 vaccine injury.
That's out of 12,358 total COVID-related claims the CICP has received, according to the latest federal data. The vast majority of those claims are still pending review. Of the 1,600 claims that the CICP has decided, roughly 98 percent were rejected.
The lawsuit filed by React19 and other patients argues the CICP's high rejection rate is a product of a flawed design that includes an exceedingly short deadline for filing for compensation and an impossibly high burden of proof for showing an injury was caused by a vaccine.
People must file a CICP claim within one year of vaccination. That compares to the VICP deadline that gives people three years following the onset of vaccine injury symptoms to file a petition.
"Most of us don't know what's wrong with us for over a year if we can ever get a diagnosis," says Dreisbach, who himself suffered a COVID-19 vaccine injury. "So many in our community don't even know the program even exists."
Of the 1,588 claims CICP has rejected, 933 of them have been for missed deadlines.
In order to get compensation through the CICP, claimants must also show "compelling, reliable, valid, medical, and scientific evidence" that their injury was caused by a COVID-19 vaccine.
By comparison, the VICP has a pretty low threshold for proving a vaccine injury. People who suffered one of several listed "table" injuries soon after receiving their vaccine are presumed to have been injured by the vaccine. Those who suffer a nontable injury need only show by a preponderance of the evidence (i.e., that it's more likely than not) that they were injured by a vaccine.
The higher burden of proof claimants must show the CICP is compounded by the fact that less scientific evidence exists about the effects of the recently invented COVID-19 vaccines.
"When you're talking 40,000 to 60,000 in a study, we know pretty well short-term side effects, but we don't have very much of an idea of what the long-term side effects will be," says Katharine Van Tassel, a law professor at Case Western Reserve School of Law who co-authored a book on the Food and Drug Administration.
Van Tassel says that while vaccines are safe, "we did not have very much time to study [COVID] vaccines, so we know the risk of injury was higher."
The CICP's high burden of proof is compounded by the fact that it's also a purely administrative process, with few guaranteed rights for those seeking compensation. Federal bureaucrats review and decide claims on their own. Claimants have no right to a lawyer to argue their case against the government, no right to submit expert evidence, and no right to appeal a rejected claim to any court.
That all contrasts with the quasi-judicial VICP, where petitioners are guaranteed a lawyer who can submit expert evidence on their behalf and a neutral special master (judge) decides cases. People in the VICP can also appeal a rejected petition all the way up to the U.S. Supreme Court. If that doesn't work, they can then sue vaccine makers in civil court.
In addition to all these problems is the fact that the CICP was, prior to COVID, a little-used program that's arguably been swamped by the huge number of claims it's received.
The CICP was first authorized in 2005 by a piece of war-on-terror legislation intended to encourage companies to produce emergency countermeasures to a bioweapons attack or a similar disaster by shielding them from lawsuits.
Prior to the pandemic, it had received only 500 claims and paid out compensation to only 30 people (mostly for swine flu vaccine injuries).
Van Tassel says that the government is within its powers to suspend people's normal right to sue companies for damages, provided that it also provides anyone claiming an injury "a reasonable alternative remedy" to sue for damages.
The CICP's high standard of proof, short filing deadlines, and lack of any real procedural rights all cause it to fall woefully short of being a "reasonable alternative remedy," she says.
The claims in the lawsuit from React19 and other plaintiffs that the CICP violates the Fifth and Seventh Amendments' guarantees of due process and jury trials are on firm ground, she says. "I think this is a very strong lawsuit," she tells Reason.
There are various congressional efforts to help those with COVID-19 vaccine injuries.
Rep. Lloyd Doggett (D–Texas) has introduced two bills that would shift COVID-19 vaccine injury claimants into the VICP and then modernize the VICP process. Another much more modest bill proposed by Sen. Robert Casey (D–Penn.) would extend the deadline for filing COVID-19 vaccine injury claims.
Last year, Sen. Mike Lee (R–Utah) also introduced a bill that would reform the CICP to make it more like the VICP program, with special masters deciding cases in federal claims court.
None of these efforts have made much headway in Congress, much to the frustration of vaccine-injured advocates.
"Our community needed help yesterday. We've been asking Congress to take action for over two years, our hope is that this lawsuit forces their hand," says Dreisbach.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.























